Asset Advisors Corp’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Asset Advisors Corp’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	$602K	Hold	6,325	–	–	0.1%	75
2018 Q1	$555K	Hold	6,325	–	–	0.09%	80
2017 Q4	$537K	Hold	6,325	–	–	0.09%	82
2017 Q3	$548K	Hold	6,325	–	–	0.1%	79
2017 Q2	$488K	Sell	6,325 -500	-7%	-$35.5K	0.09%	81
2017 Q1	$473K	Hold	6,825	–	–	0.09%	80
2016 Q4	$404K	Sell	6,825 -3,000	-31%	-$185K	0.08%	85
2016 Q3	$651K	Hold	9,825	–	–	0.14%	75
2016 Q2	$531K	Hold	9,825	–	–	0.11%	81
2016 Q1	$508K	Hold	9,825	–	–	0.11%	81
2015 Q4	$690K	Hold	9,825	–	–	0.15%	76
2015 Q3	$612K	Hold	9,825	–	–	0.15%	73
2015 Q2	$826K	Hold	9,825	–	–	0.18%	73
2015 Q1	$739K	Hold	9,825	–	–	0.17%	74
2014 Q4	$611K	Sell	9,825 -450	-4%	-$25.7K	0.13%	75
2014 Q3	$534K	Sell	10,275 -3,900	-28%	-$199K	0.12%	78
2014 Q2	$728K	Sell	14,175 -28,350	-67%	-$1.28M	0.17%	71
2014 Q1	$2.02M	Sell	42,525 -26,025	-38%	-$1.33M	0.48%	53
2013 Q4	$2.98M	Buy	68,550 +6,075	+10%	+$252K	0.71%	44
2013 Q3	$2.69M	Buy	62,475 +1,950	+3%	+$79K	0.76%	42
2013 Q2	$2.1M	Buy	+60,525	New	+$2.13M	0.62%	47

Other funds holding XBI

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

AssetMark Inc Concord, California $49B AUM 17.78% 1-Year Est. Return

Asset Advisors Corp's XBI Position: Q2 2018 in Review

Asset Advisors Corp held its State Street SPDR S&P Biotech ETF (XBI) position steady in Q2 2018 at 6,325 shares worth $602K. The position accounts for 0.1% of the portfolio, ranked #75.

Asset Advisors Corp first reported a position in XBI in Q2 2013 and has held it in 21 quarters since. The position peaked at $2.98M in Q4 2013. 431 funds tracked by Wall St. Rank hold XBI as of Q2 2018.

Asset Advisors Corp held 6,325 shares of State Street SPDR S&P Biotech ETF worth $602K as of Q2 2018.
Asset Advisors Corp left its State Street SPDR S&P Biotech ETF share count unchanged in Q2 2018.
State Street SPDR S&P Biotech ETF made up 0.1% of Asset Advisors Corp's portfolio in Q2 2018, its #75 holding.
Asset Advisors Corp first reported a position in State Street SPDR S&P Biotech ETF in Q2 2013 and has held it in 21 quarters since.
Asset Advisors Corp's State Street SPDR S&P Biotech ETF position peaked at $2.98M in Q4 2013.
431 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2018.

Based on Asset Advisors Corp's 13F filing for Q2 2018, filed 20 Jul 2018.